Company Filing History:
Years Active: 2025
Title: Lucy Hepburn: Innovator in Antibody Research
Introduction
Lucy Hepburn is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. Her work focuses on the creation of antagonists targeting Cluster of Differentiation 7 (CD7), which has important implications for medical treatments.
Latest Patents
Lucy Hepburn holds a patent for her invention titled "Antagonists anti-CD7 antibodies." This invention relates to CD7 antagonists, including antibodies and fragments, as well as methods, uses, and combinations that can be utilized in various therapeutic applications. She has successfully secured 1 patent for her groundbreaking work.
Career Highlights
Throughout her career, Lucy has been associated with Kymab Limited, a company known for its innovative approaches in the field of immunotherapy. Her role at Kymab has allowed her to contribute to the advancement of antibody research and development.
Collaborations
Lucy Hepburn has collaborated with notable colleagues, including E-Chiang Lee and Gwenoline Borhis. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
In summary, Lucy Hepburn is a distinguished inventor whose work in antibody research has the potential to impact medical treatments significantly. Her innovative spirit and dedication to advancing biotechnology continue to inspire others in the field.